Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study-Reference-Cited by-同舟云学术

Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study

Published:2023-06-06 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Guo Zhibo¹,Guo Dan¹,Kong Desheng²,Bian Sicheng¹³,Lin Leilei⁴,Fan Shengjin¹,Li Qi¹,Zhao Yanqiu¹,Jiang Yanmeng¹,Yan Jiangrong¹,Wang Zheren¹,Sun Lili¹,Li Yinghua¹^ORCID

Affiliation:

1. Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China

2. Department of Hematology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China

3. Institute of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, People’s Republic of China

4. Department of Hematology, Yantai Yuhuangding Hospital, Qingdao University Medical College, Yantai, People’s Republic of China

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2219930

Reference43 articles.

1. Acute myeloid leukaemia

2. The Impact of Epigenetic Modifications in Myeloid Malignancies

3. An update of current treatments for adult acute myeloid leukemia

4. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach

5. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine;Reactions Weekly;2024-07-27

2. Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review;Frontiers in Oncology;2024-02-21